Why Johnson & Johnson Stock Held Steady in April
Shares of Johnson & Johnson (NYSE: JNJ) climbed a mere 1.82% in April, according to data from S&P Global Market Intelligence. At another time, that would be cause for alarm, but after a month in which the S&P 500 index dropped 8.8% and the iShares US Pharmaceuticals ETF dropped 3.32%, Johnson & Johnson's steadiness is worth noting.
The healthcare stock closed March out at $177.23 a share, rising to as high as $186.69 on April 25, its 52-week zenith. It ended the month at $180.46. So far this year, the stock is up more than 8%.
Image source: Getty Images.
Source Fool.com
